Loading...
Targeting immunotherapy for bladder cancer by using anti-CD3 × CD155 bispecific antibody
To investigate whether CD155 is an attractive target for T cell-mediated immunotherapy against human bladder cancer, we examined the novel bispecific antibody anti-CD3 x anti-CD155 (CD155Bi-Ab) for its ability to redirect activated T cells (ATCs) to target bladder cancer cells was examined. Expressi...
Na minha lista:
| Udgivet i: | J Cancer |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ivyspring International Publisher
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6775611/ https://ncbi.nlm.nih.gov/pubmed/31602268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.29937 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|